Monoclonal antibodies have become the preferred therapeutic modality for cancer, infectious diseases, inflammatory and autoimmune disorders, and other conditions. Twist Bioscience is on a mission to support this work, offering a Library of Libraries containing multiple pre-constructed and validated libraries against many high-value targets with which scientists can build a comprehensive and robust antibody discovery platform. Here we introduce the latest addition to our Library of Libraries: the Hyperimmune Library. Join our webinar with Steven Thomas from Twist Biopharma, a division of Twist Bioscience, to: Review recent work from Twist Biopharma using the Library of Libraries against human ACE2 and the SARS-CoV-2 spike protein to find potently neutralizing candidate antibodies against the SARS-CoV-2 strain of coronavirus in under 4 weeks.

Twist Biopharma is committed to helping you realize the potential of your biggest biologic development programs. Wherever you are in the development pipeline, we have a solution that will elevate you to the next level of discovery.